Deoxyribozymes: cleaving a path to clinical trials

被引：44
|
作者：
Dass, CR [1 ]
机构：
[1] GeneType Res Labs, Fitzroy, Vic 3065, Australia
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2004年 / 25卷 / 08期
关键词：
D O I：
10.1016/j.tips.2004.06.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Deoxyribozymes (DNAzymes) comprise an exciting class of nucleic acid molecules that are capable of specific cleavage of target mRNA. Recent reports attest to the potential of this class of molecules in cell culture and preclinical studies, where DNAzymes exhibit the ability to silence disease-associated genes (mainly those associated with cardiovascular disease and cancer). Rigorous testing in preclinical studies is now required before this relatively new entity enters Phase I clinical trials.
引用
收藏
页码：395 / 397
页数：3
相关论文
共 50 条
  • [41] Drug development and clinical trials-the path to an approved cancer drug
    Rubin, Eric H.
    Gilliland, D. Gary
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (04) : 215 - 222
  • [42] In vitro selection of N1-methyladenosine-sensitive RNA-cleaving deoxyribozymes with 105-fold selectivity over unmethylated RNA
    Shi, Jiarong
    Zhang, Qiang
    Wu, Yunping
    Chang, Yangyang
    Liu, Meng
    CHEMICAL SCIENCE, 2024, 15 (33) : 13452 - 13458
  • [43] Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials
    Shenaq, Deana S.
    Rastegar, Farbod
    Petkovic, Djuro
    Zhang, Bing-Qiang
    He, Bai-Cheng
    Chen, Liang
    Zuo, Guo-Wei
    Luo, Qing
    Shi, Qiong
    Wagner, Eric R.
    Huang, Enyi
    Gao, Yanhong
    Gao, Jian-Li
    Kim, Stephanie H.
    Yang, Ke
    Bi, Yang
    Su, Yuxi
    Zhu, Gaohui
    Luo, Jinyong
    Luo, Xiaoji
    Qin, Jiaqiang
    Reid, Russell R.
    Luu, Hue H.
    Haydon, Rex C.
    He, Tong-Chuan
    STEM CELLS INTERNATIONAL, 2010, 2010
  • [44] Clinical trials involving carbon-ion radiation therapy and the path forward
    Lazar, Ann A.
    Schulte, Reinhard
    Faddegon, Bruce
    Blakely, Eleanor A.
    Roach, Mack, III
    CANCER, 2018, 124 (23) : 4467 - 4476
  • [45] From clinical trials to public health policy: The path from imaging to screening
    Shaw, LJ
    Redberg, RF
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 62E - 65E
  • [46] STUMBLING BLOCKS PAVE PATH TO CLINICAL-TRIALS FOR GENE-THERAPY
    MERZ, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (14): : 1825 - &
  • [47] N-1 and Sequencing Clinical Heart Failure Trials Charting the Path for Future Clinical Care
    O'Connor, Christopher M.
    JACC-HEART FAILURE, 2019, 7 (12) : 1089 - 1090
  • [48] Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials
    Bieske, Linn
    Zinner, Maximillian
    Dahlhausen, Florian
    Truebel, Hubert
    DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [49] Clinical trials and clinical trials networks
    Neto, Ary Serpa
    Bellomo, Rinaldo
    RESPIROLOGY, 2024, 29 (05) : 369 - 371
  • [50] Trials and tribulations on the path to remyelination
    Calabresi, Peter A.
    LANCET NEUROLOGY, 2021, 20 (09): : 686 - 687
12345